JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
SES AI
SES
$223M
| $212K | ﹤0.01% |
71,775
+8,789
| +14% | +$27.7K |
|
4802
John Hancock Multifactor Large Cap ETF
JHML
$1.2B
| $211K | ﹤0.01% |
4,079
| – | – |
|
4803
Digimarc Corp
DMRC
$169M
| $211K | ﹤0.01% |
10,731
+2,991
| +39% | +$60.3K |
|
4804
Edgewise Therapeutics
EWTX
$4.8B
| $210K | ﹤0.01% |
31,380
+7,063
| +29% | +$65.5K |
|
4805
PUT
MongoDB
MDB
$37B
| $210K | ﹤0.01% |
900
-7,300
| -89% | -$1.53M |
|
4806
CALL
Vaxcyte
PCVX
$8.64B
| $210K | ﹤0.01% |
+5,600
| New | +$238K |
|
4807
CarParts.com
PRTS
$47.1M
| $210K | ﹤0.01% |
3,925
-2,617
| -40% | -$166K |
|
|
SNPO
4808
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $210K | ﹤0.01% |
22,440
+4,548
| +25% | +$44.9K |
|
4809
ACNB Corp
ACNB
$660M
| $209K | ﹤0.01% |
6,431
+81
| +1% | +$2.95K |
|
4810
PUT
Inovio Pharmaceuticals
INO
$113M
| $209K | ﹤0.01% |
21,250
| – | – |
|
|
IGR
4811
CBRE Global Real Estate Income Fund
IGR
$715M
| $209K | ﹤0.01% |
39,427
+10,326
| +35% | +$64.4K |
|
4812
CALL
Autodesk
ADSK
$53.1B
| $208K | ﹤0.01% |
1,000
-1,100
| -52% | -$226K |
|
4813
Atea Pharmaceuticals
AVIR
$411M
| $208K | ﹤0.01% |
62,213
-147,805
| -70% | -$600K |
|
4814
TaskUs
TASK
$688M
| $208K | ﹤0.01% |
14,414
+2,989
| +26% | +$52K |
|
|
TECX
4815
Tectonic Therapeutic
TECX
$682M
| $208K | ﹤0.01% |
17,332
+15,365
| +781% | +$214K |
|
|
TBNK
4816
DELISTED
Territorial Bancorp Inc.
TBNK
| $208K | ﹤0.01% |
10,770
+10,745
| +42,980% | +$245K |
|
4817
PUT
Las Vegas Sands
LVS
$29.9B
| $207K | ﹤0.01% |
3,600
-89,300
| -96% | -$5M |
|
4818
Noodles & Co
NDLS
$107M
| $207K | ﹤0.01% |
5,345
+211
| +4% | +$9.63K |
|
|
EIGR
4819
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $207K | ﹤0.01% |
7,689
+3,938
| +105% | +$183K |
|
4820
Dorchester Minerals
DMLP
$1.36B
| $205K | ﹤0.01% |
6,781
-126,780
| -95% | -$3.75M |
|
4821
PUT
HP
HPQ
$27.5B
| $205K | ﹤0.01% |
+7,000
| New | +$201K |
|
|
EVBN
4822
DELISTED
Evans Bancorp Inc
EVBN
| $205K | ﹤0.01% |
6,105
+6,095
| +60,950% | +$231K |
|
4823
Ericsson
ERIC
$33.6B
| $204K | ﹤0.01% |
35,008
+3,105
| +10% | +$17.7K |
|
4824
Greystone Housing Impact Investors LP
GHI
$141M
| $204K | ﹤0.01% |
12,004
+123
| +1% | +$2.18K |
|
|
NCV
4825
Virtus Convertible & Income Fund
NCV
$392M
| $203K | ﹤0.01% |
+15,050
| New | +$220K |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.